CA2097305A1 - Procede en solution pour la synthese d'un peptide - Google Patents

Procede en solution pour la synthese d'un peptide

Info

Publication number: CA2097305A1
Authority: CA; Canada
Prior art keywords: boc; trp; lys; phe; ala
Prior art date: 1990-11-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002097305A

Other languages

English (en)

Inventor

David Stevenson

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SmithKline Beecham Corp

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-11-30

Filing date

1991-11-25

Publication date

1992-05-31

1991-11-25 Application filed by Individual filed Critical Individual

1992-05-31 Publication of CA2097305A1 publication Critical patent/CA2097305A1/fr

Status Abandoned legal-status Critical Current

Links

238000000034 method Methods 0.000 title claims description 28
108090000765 processed proteins & peptides Proteins 0.000 title abstract description 11
230000015572 biosynthetic process Effects 0.000 title description 2
238000003786 synthesis reaction Methods 0.000 title 1
238000004519 manufacturing process Methods 0.000 claims abstract description 8
239000007787 solid Substances 0.000 claims description 25
-1 carbonium ion Chemical class 0.000 claims description 21
238000005859 coupling reaction Methods 0.000 claims description 16
230000008878 coupling Effects 0.000 claims description 15
238000010168 coupling process Methods 0.000 claims description 15
150000001875 compounds Chemical class 0.000 claims description 14
125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 claims description 11
FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 claims description 10
KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 10
239000002253 acid Substances 0.000 claims description 10
DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 9
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 8
238000007327 hydrogenolysis reaction Methods 0.000 claims description 7
239000003153 chemical reaction reagent Substances 0.000 claims description 6
239000003054 catalyst Substances 0.000 claims description 4
230000003197 catalytic effect Effects 0.000 claims description 4
TYRGLVWXHJRKMT-QMMMGPOBSA-N n-benzyloxycarbonyl-l-serine-betalactone Chemical compound OC(=O)[C@H](C)NC(=O)OCC1=CC=CC=C1 TYRGLVWXHJRKMT-QMMMGPOBSA-N 0.000 claims description 4
239000002516 radical scavenger Substances 0.000 claims description 3
125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 3
UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 claims 9
125000006239 protecting group Chemical group 0.000 claims 2
ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 claims 1
SUVIGLJNEAMWEG-UHFFFAOYSA-N propane-1-thiol Chemical group CCCS SUVIGLJNEAMWEG-UHFFFAOYSA-N 0.000 claims 1
102000018997 Growth Hormone Human genes 0.000 abstract description 2
108010051696 Growth Hormone Proteins 0.000 abstract description 2
239000000122 growth hormone Substances 0.000 abstract description 2
230000003578 releasing effect Effects 0.000 abstract description 2
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 31
239000000243 solution Substances 0.000 description 27
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 25
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 24
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 24
150000002500 ions Chemical class 0.000 description 21
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 16
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 15
239000000543 intermediate Substances 0.000 description 14
238000003756 stirring Methods 0.000 description 13
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
238000006243 chemical reaction Methods 0.000 description 11
238000004128 high performance liquid chromatography Methods 0.000 description 11
239000000047 product Substances 0.000 description 10
239000000706 filtrate Substances 0.000 description 9
239000011541 reaction mixture Substances 0.000 description 9
239000000377 silicon dioxide Substances 0.000 description 8
238000005406 washing Methods 0.000 description 8
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 7
IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 6
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
230000007935 neutral effect Effects 0.000 description 6
239000012071 phase Substances 0.000 description 6
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 5
238000005481 NMR spectroscopy Methods 0.000 description 5
238000004992 fast atom bombardment mass spectroscopy Methods 0.000 description 5
239000000203 mixture Substances 0.000 description 5
LXMSZDCAJNLERA-ZHYRCANASA-N spironolactone Chemical compound C([C@@H]1[C@]2(C)CC[C@@H]3[C@@]4(C)CCC(=O)C=C4C[C@H]([C@@H]13)SC(=O)C)C[C@@]21CCC(=O)O1 LXMSZDCAJNLERA-ZHYRCANASA-N 0.000 description 5
239000007858 starting material Substances 0.000 description 5
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
239000011591 potassium Substances 0.000 description 4
229910052700 potassium Inorganic materials 0.000 description 4
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
239000011347 resin Substances 0.000 description 4
229920005989 resin Polymers 0.000 description 4
USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 3
239000005695 Ammonium acetate Substances 0.000 description 3
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 3
239000004472 Lysine Substances 0.000 description 3
LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
229910019142 PO4 Inorganic materials 0.000 description 3
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
229940024606 amino acid Drugs 0.000 description 3
235000001014 amino acid Nutrition 0.000 description 3
150000001413 amino acids Chemical class 0.000 description 3
229940043376 ammonium acetate Drugs 0.000 description 3
235000019257 ammonium acetate Nutrition 0.000 description 3
238000009835 boiling Methods 0.000 description 3
229910052799 carbon Inorganic materials 0.000 description 3
239000008367 deionised water Substances 0.000 description 3
229910021641 deionized water Inorganic materials 0.000 description 3
NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 description 3
239000012153 distilled water Substances 0.000 description 3
229910052739 hydrogen Inorganic materials 0.000 description 3
239000001257 hydrogen Substances 0.000 description 3
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
239000010452 phosphate Substances 0.000 description 3
TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 3
239000000843 powder Substances 0.000 description 3
DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 3
VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
125000006847 BOC protecting group Chemical group 0.000 description 2
RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 2
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
125000002707 L-tryptophyl group Chemical group [H]C1=C([H])C([H])=C2C(C([C@](N([H])[H])(C(=O)[*])[H])([H])[H])=C([H])N([H])C2=C1[H] 0.000 description 2
229960003767 alanine Drugs 0.000 description 2
229910000147 aluminium phosphate Inorganic materials 0.000 description 2
LFVGISIMTYGQHF-UHFFFAOYSA-N ammonium dihydrogen phosphate Chemical compound [NH4+].OP(O)([O-])=O LFVGISIMTYGQHF-UHFFFAOYSA-N 0.000 description 2
229910000387 ammonium dihydrogen phosphate Inorganic materials 0.000 description 2
239000000908 ammonium hydroxide Substances 0.000 description 2
RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
150000001718 carbodiimides Chemical class 0.000 description 2
239000012065 filter cake Substances 0.000 description 2
239000000463 material Substances 0.000 description 2
235000019837 monoammonium phosphate Nutrition 0.000 description 2
229940099990 ogen Drugs 0.000 description 2
229910000027 potassium carbonate Inorganic materials 0.000 description 2
235000011181 potassium carbonates Nutrition 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
239000000725 suspension Substances 0.000 description 2
RRONHWAVOYADJL-OAHLLOKOSA-N (2r)-3-phenyl-2-(phenylmethoxycarbonylamino)propanoic acid Chemical compound C([C@H](C(=O)O)NC(=O)OCC=1C=CC=CC=1)C1=CC=CC=C1 RRONHWAVOYADJL-OAHLLOKOSA-N 0.000 description 1
DYSBKEOCHROEGX-HNNXBMFYSA-N (2s)-6-[(2-methylpropan-2-yl)oxycarbonylamino]-2-(phenylmethoxycarbonylamino)hexanoic acid Chemical compound CC(C)(C)OC(=O)NCCCC[C@@H](C(O)=O)NC(=O)OCC1=CC=CC=C1 DYSBKEOCHROEGX-HNNXBMFYSA-N 0.000 description 1
238000005160 1H NMR spectroscopy Methods 0.000 description 1
239000005745 Captan Substances 0.000 description 1
QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
229930182832 D-phenylalanine Natural products 0.000 description 1
COLNVLDHVKWLRT-MRVPVSSYSA-N D-phenylalanine Chemical compound OC(=O)[C@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-MRVPVSSYSA-N 0.000 description 1
125000001711 D-phenylalanine group Chemical group [H]N([H])[C@@]([H])(C(=O)[*])C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
229930182827 D-tryptophan Natural products 0.000 description 1
125000003941 D-tryptophan group Chemical group [H]C1=C([H])C([H])=C2C(C([C@@](N([H])[H])(C(=O)[*])[H])([H])[H])=C([H])N([H])C2=C1[H] 0.000 description 1
QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 description 1
101100042648 Drosophila melanogaster sing gene Proteins 0.000 description 1
KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
206010056438 Growth hormone deficiency Diseases 0.000 description 1
235000008694 Humulus lupulus Nutrition 0.000 description 1
244000025221 Humulus lupulus Species 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
235000019766 L-Lysine Nutrition 0.000 description 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
241000283986 Lepus Species 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 1
238000010306 acid treatment Methods 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
125000002252 acyl group Chemical group 0.000 description 1
229940094070 ambien Drugs 0.000 description 1
229910021529 ammonia Inorganic materials 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
229940117949 captan Drugs 0.000 description 1
125000005626 carbonium group Chemical group 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
239000013078 crystal Substances 0.000 description 1
125000004122 cyclic group Chemical group 0.000 description 1
238000000354 decomposition reaction Methods 0.000 description 1
238000010511 deprotection reaction Methods 0.000 description 1
238000001514 detection method Methods 0.000 description 1
125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
MKRTXPORKIRPDG-UHFFFAOYSA-N diphenylphosphoryl azide Chemical compound C=1C=CC=CC=1P(=O)(N=[N+]=[N-])C1=CC=CC=C1 MKRTXPORKIRPDG-UHFFFAOYSA-N 0.000 description 1
230000008034 disappearance Effects 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
230000000694 effects Effects 0.000 description 1
238000010828 elution Methods 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
229960002885 histidine Drugs 0.000 description 1
239000005556 hormone Substances 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
238000005984 hydrogenation reaction Methods 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
239000012528 membrane Substances 0.000 description 1
UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
239000011707 mineral Substances 0.000 description 1
235000010755 mineral Nutrition 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
229910000069 nitrogen hydride Inorganic materials 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
238000012856 packing Methods 0.000 description 1
229910052763 palladium Inorganic materials 0.000 description 1
230000001817 pituitary effect Effects 0.000 description 1
239000011148 porous material Substances 0.000 description 1
235000015497 potassium bicarbonate Nutrition 0.000 description 1
239000011736 potassium bicarbonate Substances 0.000 description 1
229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
238000000746 purification Methods 0.000 description 1
238000001953 recrystallisation Methods 0.000 description 1
239000007790 solid phase Substances 0.000 description 1
238000010532 solid phase synthesis reaction Methods 0.000 description 1
241000894007 species Species 0.000 description 1
229910001220 stainless steel Inorganic materials 0.000 description 1
239000010935 stainless steel Substances 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
229960004799 tryptophan Drugs 0.000 description 1
238000000825 ultraviolet detection Methods 0.000 description 1
ABDKAPXRBAPSQN-UHFFFAOYSA-N veratrole Chemical compound COC1=CC=CC=C1OC ABDKAPXRBAPSQN-UHFFFAOYSA-N 0.000 description 1
ZAFYATHCZYHLPB-UHFFFAOYSA-N zolpidem Chemical compound N1=C2C=CC(C)=CN2C(CC(=O)N(C)C)=C1C1=CC=C(C)C=C1 ZAFYATHCZYHLPB-UHFFFAOYSA-N 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
- C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
- C07K1/064—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for omega-amino or -guanidino functions

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Analytical Chemistry (AREA)
Endocrinology (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

CA002097305A 1990-11-30 1991-11-25 Procede en solution pour la synthese d'un peptide Abandoned CA2097305A1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US62109490A	1990-11-30	1990-11-30
US07/621,094		1990-11-30

Publications (1)

Publication Number	Publication Date
CA2097305A1 true CA2097305A1 (fr)	1992-05-31

Family

ID=24488689

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002097305A Abandoned CA2097305A1 (fr)	1990-11-30	1991-11-25	Procede en solution pour la synthese d'un peptide

Country Status (10)

Country	Link
EP (1)	EP0564587A4 (fr)
JP (1)	JPH06503578A (fr)
KR (1)	KR930703345A (fr)
AU (1)	AU9166491A (fr)
CA (1)	CA2097305A1 (fr)
IE (1)	IE914157A1 (fr)
MX (1)	MX9102333A (fr)
PT (1)	PT99654A (fr)
WO (1)	WO1992009620A1 (fr)
ZA (1)	ZA919440B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3480848B2 (ja) *	1992-06-19	2003-12-22	タカラバイオ株式会社	環状ペプチドの合成方法
GB0814519D0 (en) *	2008-08-08	2008-09-17	Imp Innovations Ltd	Process

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4411890A (en) *	1981-04-14	1983-10-25	Beckman Instruments, Inc.	Synthetic peptides having pituitary growth hormone releasing activity
US4105652A (en) *	1977-08-05	1978-08-08	Hoffmann-La Roche Inc.	Synthesis of human β-endorphin
US4237046A (en) *	1979-04-27	1980-12-02	Miklos Bodanszky	Polypeptides and methods of preparation
WO1992001709A1 (fr) *	1990-07-24	1992-02-06	Eastman Kodak Company	Procede de synthese de peptides

1991
- 1991-11-25 JP JP4503322A patent/JPH06503578A/ja active Pending
- 1991-11-25 KR KR1019930701616A patent/KR930703345A/ko not_active Withdrawn
- 1991-11-25 AU AU91664/91A patent/AU9166491A/en not_active Abandoned
- 1991-11-25 CA CA002097305A patent/CA2097305A1/fr not_active Abandoned
- 1991-11-25 WO PCT/US1991/008863 patent/WO1992009620A1/fr not_active Ceased
- 1991-11-25 EP EP9292903706A patent/EP0564587A4/en not_active Withdrawn
- 1991-11-29 IE IE415791A patent/IE914157A1/en not_active Application Discontinuation
- 1991-11-29 PT PT99654A patent/PT99654A/pt not_active Application Discontinuation
- 1991-11-29 ZA ZA919440A patent/ZA919440B/xx unknown
- 1991-12-02 MX MX9102333A patent/MX9102333A/es unknown

Also Published As

Publication number	Publication date
AU9166491A (en)	1992-06-25
JPH06503578A (ja)	1994-04-21
ZA919440B (en)	1992-12-30
EP0564587A4 (en)	1994-08-24
MX9102333A (es)	1993-06-01
EP0564587A1 (fr)	1993-10-13
KR930703345A (ko)	1993-11-29
PT99654A (pt)	1992-10-30
IE914157A1 (en)	1992-06-03
WO1992009620A1 (fr)	1992-06-11

Legal Events

Date	Code	Title	Description
1995-05-27	FZDE	Dead

Publication	Publication Date	Title
CN109836455B (zh)	2021-11-16	基于磷或亚磷酰氧基二苯甲醇及其衍生物及辅助的胸腺五肽液相合成方法
CN101279998B (zh)	2011-07-06	一种c-端乙胺化多肽及其衍生物的制备方法
CN109096388A (zh)	2018-12-28	一种特立帕肽的制备方法
CN104004064A (zh)	2014-08-27	一种布舍瑞林的制备方法
CA2097305A1 (fr)	1992-05-31	Procede en solution pour la synthese d'un peptide
JPH0377178B2 (fr)	1991-12-09
CN104817638A (zh)	2015-08-05	一种合成替度鲁肽的方法
CN120271660B (zh)	2025-08-19	一种高效选择性拮抗剂bq-788的制备方法
CN113150108B (zh)	2022-07-22	一种利拉鲁肽的固相合成方法
US5712367A (en)	1998-01-27	Process for the solubilization of peptides and process for peptide synthesis
CN110903352A (zh)	2020-03-24	一种西曲瑞克的制备方法
AU2004262570B2 (en)	2008-06-19	Preparation of somatostatin peptides
CN108484735A (zh)	2018-09-04	一类广泛活性环七肽Reniochalistatin A-D的合成方法
CN103172704A (zh)	2013-06-26	一种抗肿瘤小肽FpAT的制备方法
KR100336139B1 (ko)	2002-09-25	신규의펩티드활성물질및그의제조방법
US4923966A (en)	1990-05-08	Use of guanidine-related compounds comprising a tetraphenyl-borate ion in solution phase peptide synthesis
US5262567A (en)	1993-11-16	Compound including a guanidine group and an unsubstituted tetraphenylborate ion
SI9200212A (sl)	1994-03-31	Postopek za pripravo n-[1(s)-etoksikarbonil-3-fenilpropil]-l-alanina
CN114057829A (zh)	2022-02-18	一种n-甲基化多肽的固相合成方法
JPH06298798A (ja)	1994-10-25	エルカトニンの製造方法
JPS6022919B2 (ja)	1985-06-04	Ｎ―ベンジルオキシカルボニル‐ｌ‐アスパチル‐ｌ‐フエニルアラニンメチルエステルとフエニルアラニンメチルエステルとの付加化合物の製造方法
Gitu et al.	0	Bepartment of Chemistry, University of Nairobi, PO Box 30197, Nairobi, Kenya (Received November 19, 1997)
JPH01128998A (ja)	1989-05-22	オクタペプチドの新規な製造方法
Gao et al.	2000	Decomposition of amino acid cupric complex by using tetrahydrothiazole-2-thione for preparation of N-Boc-N€
Xu et al.	0	Solid-phase Peptide Synthesis According to Fmoc-strategy